Skip to main content

Kestra Medical Technologies, Ltd.

corporate_fare Company Profile

Kestra Medical Technologies, Ltd.

KMTS·NASDAQ·Industrial Applications And Services·CIK 0001877184

Kestra Medical Technologies, Ltd. is a commercial-stage wearable medical device and digital healthcare company that focuses on improving patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company develops and commercializes the Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at high risk of sudden cardiac arrest (SCA) during vulnerable recovery periods. The Cardiac Recovery System platform is centered on the ASSURE® Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected. The platform also incorporates digital patient engagement and clinical workflow solutions aimed at improving patient adherence, supporting care coordination, and providing actionable clinical insights throughout the recovery process. Kestra believes the ASSURE WCD stands out due to its patient-centered design, which includes comfort, wearability, and low false alarm rates, intended to improve patient compliance during extended wear periods. Additionally, the integrated platform generates continuous cardiac rhythm data and clinically actionable insights that can assist healthcare providers in managing patients during vulnerable recovery periods. As of April 30, 2026, the ASSURE WCD has protected nearly 40,000 patients since its commercial launch.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for KMTS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 8/10, with 5 rated 8 or above. Recent SEC coverage for KMTS spans 10-Q, 8-K, 10-K, 144.

Recent high-impact activity:

  • ASSURE Defibrillator Study Meets Endpoints; All 303 Shock Events Converted
  • Kestra 10-Q Reveals Material Weaknesses in Financial Controls Alongside 60% Revenue Growth
  • Kestra Medical Delivers 60% Revenue Growth and Lifts FY27 Guidance to $141M
  • Kestra Medical Lifts FY27 Revenue Outlook to $141M
  • Kestra FY26 Revenue Jumps 59% to $95M, Guides FY27 at $137M; Refinances Debt with $200M Term Loan

Financial Snapshot

Fiscal year ended April 30, 2026
Revenue
$95.13M
Net Income
-$131.61M
Diluted EPS
-$2.43
Op. Cash Flow
-$81.7M
Free Cash Flow
-$116.59M
Gross Profit
$48.86M
Operating Income
-$134.74M
Cash & Equivalents
$99.71M
Total Debt
$42.65M
Debt / Equity
0.16×
Net Margin
-138.4%
Shares Outstanding
58.38M sh
Source: 10-K · filed 2026-07-14 · accession 0001193125-26-303397

Short Interest & Short Volume

8.15 days to cover

FINRA reported short interest of 4,104,243 shares in KMTS as of the October 30, 2026 settlement, a 19.7% increase from the prior period — about 8.2 days to cover at its recent average daily volume. On November 19, 2026, 72.1% of KMTS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,104,243 shares as of October 30, 2026
Change vs prior period▲ 19.7%
Days to cover8.15 at avg daily volume of 503,879
Daily short volume (FINRA facilities)72.1% of 144,252 shares on November 19, 2026
5-day average short volume72.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with K →
$26.37 -0.98% today
52-week range · as of 2026-09-14 $17.34 – $30
Market cap
$1.57B
Volume
78.6K (0.2× avg)
3-mo avg 471.5K
Live data · 2026-11-20 17:34 UTC · Market open

show_chartPrice Chart

Loading chart...

feed KMTS - Latest Insights

KMTS
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $28.64
Real-time Price: $26.37 info
Change: -$2.27 (-8%) info
Market Cap: $1.566B info
KMTS
Sep 14, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $21.70
Real-time Price: $26.37 info
Change: +$4.67 (+22%) info
Market Cap: $1.566B info
KMTS
Sep 14, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $23.16
Real-time Price: $26.37 info
Change: +$3.21 (+14%) info
Market Cap: $1.566B info
KMTS
Sep 14, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $24.00
Real-time Price: $26.37 info
Change: +$2.37 (+10%) info
Market Cap: $1.566B info
KMTS
Jul 14, 2026, 5:16 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $24.22
Real-time Price: $26.37 info
Change: +$2.15 (+9%) info
Market Cap: $1.566B info
KMTS
Jul 14, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $24.18
Real-time Price: $26.37 info
Change: +$2.19 (+9%) info
Market Cap: $1.566B info
KMTS
Jul 14, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $24.18
Real-time Price: $26.37 info
Change: +$2.19 (+9%) info
Market Cap: $1.566B info
KMTS
May 15, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $19.82
Real-time Price: $26.37 info
Change: +$6.55 (+33%) info
Market Cap: $1.566B info
KMTS
Apr 22, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $23.20
Real-time Price: $26.37 info
Change: +$3.18 (+14%) info
Market Cap: $1.566B info
KMTS
Mar 17, 2026, 6:17 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $19.27
Real-time Price: $26.37 info
Change: +$7.10 (+37%) info
Market Cap: $1.566B info
KMTS
Mar 17, 2026, 5:14 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $19.27
Real-time Price: $26.37 info
Change: +$7.10 (+37%) info
Market Cap: $1.566B info
KMTS
Mar 17, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.14
Real-time Price: $26.37 info
Change: +$5.23 (+25%) info
Market Cap: $1.566B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets